BIOLANE PHARM IRENA CHOJNACKA SPÓŁKA KOMANDYTOWA
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
BIOLANE PHARM IRENA CHOJNACKA SPÓŁKA KOMANDYTOWA
Contacts
Registered address
Copy
Website
-
Not calculatedReliability
Prescore cannot be calculated because the company delayed submission of financial statements.
Incorporation date
07/03/2022Share capital
No dataPrimary activity
Dispensing chemist in specialized stores (47.73.Z - PKD 2007)Representatives
0Representatives rights
SPÓŁKĘ REPREZENTUJĄ KOMPLEMENTARIUSZE: IRENA CHOJNACKA I SYLWIA CHOJNACKA - GORDON, KAŻDY Z KOMPLEMENTARIUSZY MA PRAWO DO SAMODZIELNEJ REPREZENTACJI SPÓŁKIRepresentatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
2,222,718Net Profit (zł)
2,222,718Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 5,036,286 |
| 1,935,058 |
| 1,760,273 |
| 0.43 |
| 2.02 |
| 34.95 |
| 2,192,307 |
| 2,145,458 |
| - |
| - |
| 2023 |
|---|
| 6,503,188 |
| 2,443,073 |
| 2,222,718 |
| 0.68 |
| 71.76 |
| 34.18 |
| 4,415,024 |
| 62,218 |
| - |
| - |
| 2023 |
|---|
| 6,503,188 |
| 2,443,073 |
| 2,222,718 |
| 0.68 |
| 71.76 |
| 34.18 |
| 4,415,024 |
| 62,218 |
| - |
| - |
Turnover (zł)
2023
Turnover (zł)
6,503,188 zł
29 % *
Profit before tax (zł)
2,443,073 zł26 % *
Net Profit (zł)
2,222,718 zł26 % *
Working capital requirement (%)
0.68 
58.14 % *
Liquidity ratio
71.76 3,452.48 % *
Net profitability (%)
34.18 %
-2.20 % *
Equity (zł)
4,415,024 zł101 % *
Current liabilities (zł)
62,218 zł-97 % *
Non current liabilities (zł)
-Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
BIOLANE PHARM IRENA CHOJNACKA SPÓŁKA KOMANDYTOWA Documents
Date | Description |
|---|---|
04/12/2024 | OD 01.01.2023 DO 31.12.2023 |
04/12/2024 | OD 07.03.2022 DO 31.12.2022 |